Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea

British Journal of Oral and Maxillofacial Surgery

Volumn 51, Issue 2, 2013, Pages 113-116

  Sidebottom, A J ^a   May, J E ^a   Madahar, A K ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Botulinum toxin; Children; Hypersalivation; Neuromuscular disorders; Sialorrhoea

Indexed keywords

ANESTHETIC AGENT; BOTULINUM TOXIN A; SCOPOLAMINE; DIAGNOSTIC AGENT; MUSCLE RELAXANT AGENT;

ADOLESCENT; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; EAR NOSE THROAT SURGERY; ECHOGRAPHY; EPILEPSY; FEMALE; GENERAL ANESTHESIA; HUMAN; HYPERSALIVATION; IDIOPATHIC DISEASE; INFANTILE SPASM; MALE; MENTAL DEFICIENCY; MOTOR COORDINATION; MYOTONIC DYSTROPHY; NEUROFIBROMATOSIS; NEUROLOGICAL COMPLICATION; NEUROMUSCULAR DISEASE; OUTCOME ASSESSMENT; PALPATION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; SALIVATION; SUBMANDIBULAR GLAND; SUBMANDIBULAR GLAND REMOVAL; SWALLOWING; XEROSTOMIA; DRUG EFFECT; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; INJECTION; PATIENT CARE PLANNING; PRESCHOOL CHILD; SECRETION (PROCESS); SECRETION RATE; TREATMENT OUTCOME;

ADOLESCENT; BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DEGLUTITION DISORDERS; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; NEUROMUSCULAR AGENTS; NEUROMUSCULAR DISEASES; PALPATION; PATIENT CARE PLANNING; PROSPECTIVE STUDIES; SECRETORY RATE; SIALORRHEA; SUBMANDIBULAR GLAND; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84883047704     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2012.03.024     Document Type: Article

References (17)

1. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73-81.
2. Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hülst K, Rotteveel JJ. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 2004;1143:620-7.
3. Porta M, Gamba M, Bertacchi G., Vaj P. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. Journal of Neurology, Neurosurgery and Psychiatry 2001;70:538-40.
4. Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hülst K, Gabreëls FJ. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. European Journal of Pediatrics 2001;160:509-12.
5. Pal PK, Calne DB, Calne S, Tsui JK Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54:244-7.
6. Friedman A, Potulska A. Quantitative assessment of Parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism & Related Disorders 2001;7:329-32.
7. Racette BA, Good L, Sagitto S, Perlmutter JS. BotulinumtoxinB reduces sialorrhoea in Parkinsonism. Movement Disorders 2003;18:1059-61.
8. Jost WH. Treatment of drooling in Parkinson's disease with botulinum toxin. Movement Disorders 1999;14:1057.
9. Winterholler MG, Erbguth FJ, Wolf S, Kat S. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. Journal of Neurology, Neurosurgery and Psychiatry 2001;70:417-8.
10. Jongerius PH, Joosten F, Hoogen F.J., Gabreëls FJ, Rotteveel JJ. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 2003;113:107-11.
11. Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hülst K, van den Hoogen FJ. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 2004;63:1371-5.
12. Beuche W, Arglebe C, Laskawi R. Quantitative reduction of saliva production in two ALS patients with intraglandular injections of botulinum toxin. Neurology, Psychiatry and Brain Research 2000;8:23-6.
13. Reddihough D, Erasmus CE, Johnson H, McKellar G.M., Jongerius PH, Cerebral Palsy Institute. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. European Journal of Neurology 2010;17(Suppl. 2):109-21.
14. Wilkie TF The surgical treatment of drooling. A follow-up report of five years' experience. Plastic and Reconstructive Surgery 1970;45:549-54.
15. Basciani M, Di Rienzo F, Fontana A, Copetti M., Pellegrini F, Intiso D. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses. Developmental Medicine and Child Neurology 2011;53:559-64.
16. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. Journal of Oral and Maxillofacial Surgery 2003;61: 454-7.
17. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C., Beuche W. Botulinum toxin to reduce saliva flow: selected indications for ultrasound guided toxin application into salivary glands. Laryngoscope 2002;112:82-6.